Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-28 | Seres Therapeutics, Inc. | von Moltke Lisa
(See Remarks) |
S | Common Stock | D | 4334 | $0.69 - $0.69 | $2,991 |
| 2024-10-27 | Seres Therapeutics, Inc. | von Moltke Lisa
(See Remarks) |
M | Common Stock | A | 13744 | $0.00 - $0.00 | $0 |
| 2024-10-28 | Seres Therapeutics, Inc. | Henn Matthew R.
(See Remarks) |
S | Common Stock | D | 3984 | $0.69 - $0.69 | $2,749 |
| 2024-10-27 | Seres Therapeutics, Inc. | Henn Matthew R.
(See Remarks) |
M | Common Stock | A | 12622 | $0.00 - $0.00 | $0 |
| 2024-10-28 | Seres Therapeutics, Inc. | DesRosier Thomas
(Chief Legal Officer and EVP) |
S | Common Stock | D | 4259 | $0.69 - $0.69 | $2,939 |
| 2024-10-27 | Seres Therapeutics, Inc. | DesRosier Thomas
(Chief Legal Officer and EVP) |
M | Common Stock | A | 13500 | $0.00 - $0.00 | $0 |
| 2024-10-28 | Seres Therapeutics, Inc. | Shaff Eric D.
(CEO and President) |
S | Common Stock | D | 8748 | $0.69 - $0.69 | $6,036 |
| 2024-10-27 | Seres Therapeutics, Inc. | Shaff Eric D.
(CEO and President) |
M | Common Stock | A | 27837 | $0.00 - $0.00 | $0 |
| 2024-10-28 | Seres Therapeutics, Inc. | Young Teresa L.
(See Remarks) |
S | Common Stock | D | 2983 | $0.69 - $0.69 | $2,058 |
| 2024-10-27 | Seres Therapeutics, Inc. | Young Teresa L.
(See Remarks) |
M | Common Stock | A | 11360 | $0.00 - $0.00 | $0 |
| 2024-08-16 | Seres Therapeutics, Inc. | DesRosier Thomas
(Chief Legal Officer and EVP) |
S | Common Stock | D | 873 | $0.84 - $0.84 | $733 |
| 2024-08-16 | Seres Therapeutics, Inc. | von Moltke Lisa
(See Remarks) |
S | Common Stock | D | 973 | $0.84 - $0.84 | $817 |
| 2024-08-16 | Seres Therapeutics, Inc. | Henn Matthew R.
(See Remarks) |
S | Common Stock | D | 923 | $0.84 - $0.84 | $775 |
| 2024-08-16 | Seres Therapeutics, Inc. | Shaff Eric D.
(CEO and President) |
S | Common Stock | D | 2518 | $0.84 - $0.84 | $2,115 |
| 2024-08-16 | Seres Therapeutics, Inc. | Young Teresa L.
(See Remarks) |
S | Common Stock | D | 728 | $0.84 - $0.84 | $611 |
| 2024-08-16 | Seres Therapeutics, Inc. | Ege David S.
(See Remarks) |
S | Common Stock | D | 1128 | $0.84 - $0.84 | $947 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |